A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort

Springer Science and Business Media LLC - 2021
Belén Ruiz-Antorán1, Aránzazu Sancho-López1, Ferrán Torres2,3, Ana Fernández-Cruz4
1Clinical Pharmacology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
2Medical Statistics Core Facility, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic, Barcelona, Spain
3Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Barcelona, Spain
4Infectious Diseases Unit, Internal Medicine Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ruiz-Antorán B, Sancho-López A, Torres F, Moreno-Torres V, et al. Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study. Infect Dis Ther. 2020. https://doi.org/10.1007/s40121-020-00373-8.

Janapala RN, Patel J, Belfaqeeh O, Alhashmi A, Pourmand A. Tocilizumab and steroids, mortality benefits in severe COVID-19 patients. Infect Dis Ther. 2021

Horby PW, Pessoa-Amorim G, Peto L, et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv. 2021. https://doi.org/10.1101/2021.02.11.21249258.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả